British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	GeDDIS
Description	Phase III prospective randomised controlled trial of gemcitabine+docetaxel compared with doxorubicin as first line treatment in previously untreated locally advanced, unresectable or metastatic soft tissue sarcoma
Reference	ISRCTN 07742377 NCRN portfolio
Status / Sites	OPEN Birmingham, Bristol, Cambridge, Cheltenham, Exeter, Glasgow, Leeds, Leicester, London, Manchester, Northwood, Norwich, Nottingham, Sheffield, Stanmore, Sutton
UK Chief Investigator Contact	Dr Beatrice Seddon, London

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.